AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. BIIB
  4. [Form 4] Biogen Inc. Insider Trading Activity

[Form 4] Biogen Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source:

Stock BIIB logo
Biogen Inc

NASDAQ:BIIB

BIIB Rankings

#577 Ranked by Market Cap
N/A Ranked by Dividends

BIIB Latest News

Aug 25, 2025
Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
Aug 25, 2025
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI庐聽(lecanemab)
Aug 11, 2025
Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome
Jul 30, 2025
Two-Year AG真人官方-World Study of LEQEMBI庐 in the United States聽Presented at Alzheimer's Association International Conference (AAIC) 2025
Jul 30, 2025
New Data Presented at AAIC Demonstrates Investigational LEQEMBI庐 (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease

BIIB Latest SEC Filings

Jul 31, 2025
[8-K] Biogen Inc. Reports Material Event
Jul 31, 2025
[10-Q] Biogen Inc. Quarterly Earnings Report
Jul 8, 2025
[144] Biogen Inc. SEC Filing
Jul 7, 2025
[8-K] Biogen Inc. Reports Material Event
Jun 23, 2025
[8-K] Biogen Inc. Reports Material Event

BIIB Stock Data

20.42B
146.36M
0.15%
92.62%
2.7%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
United States
CAMBRIDGE